What is Wegovy®? WEGOVY® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity: to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight. that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off. Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines. It is not known if Wegovy® is safe and effective for use in children under 12 years of age.
59118Wegovy Semaglutide 1.7Mg Pen 4 Doses is an innovative injectable medication aimed at aiding weight loss and minimizing cardiovascular risks for adults and children aged 12 and above struggling with obesity or weight-related medical issues.
Key Features
Benefits
Directions for Use